摘要
目的分析比较医药共同建立严重肾功能减退患者说明书禁用药品临床使用路径前后药师对该类药物的干预效果,探讨临床药师促进临床合理用药的有效途径。方法2021年1-6月临床药师对于首都医科大学宣武医院肾科住院的严重肾功能减退患者说明书禁用药品进行审核及干预并记录干预结果,2021年7月,通过医药沟通建立被干预药品的临床使用路径,2021年8月-2022年1月,再次对首都医科大学宣武医院肾科住院的严重肾功能减退患者的禁用药品根据临床路径进行审核干预并记录干预结果,与2021年1-6月的干预问题及干预结果进行比较。结果2021年1-6月,药师审核发现严重肾功能减退患者使用说明书禁用药品9种并进行干预,其中5种药品临床拒绝停用,4种药品临床接受干预停用,但之后均重复出现。2021年8月-2022年1月,根据临床路径,对之前干预的9种药品进行审核,有2种药品仍出现问题,但药师干预后均被临床接受,且均未重复出现。结论医药共同建立临床路径可能是促进临床合理用药的一条有效途径。
Objective To analyze the effect of pharmacists′intervention on the banned drugs in patients with severe renal impairment before and after the establishment of the clinical pathway jointly by pharmacists and physicians,and to explore the effective ways for clinical pharmacists to promote clinical rational drug use.Methods From January to June 2021,clinical pharmacists reviewed and intervened in the prohibited drugs in the patients with severe renal dysfunction in the Nephrology Department of Xuanwu Hospital of Capital Medical University,and recorded the intervention results.In July 2021,the clinical use pathway of the intervened drugs was established through medical communication.From August 2021 to January 2022,the intervened drugs were reviewed and intervened according to the clinical pathway;the intervention results were recorded and compared with those from January to June 2021.Results From January to June 2021,pharmacists found that 9 drugs banned in the instructions were used by patients with severe renal impairment and gave interventions.Five drugs were refused to be discontinued by physicians,and 4 were discontinued,but all were re-used after interventions.From August 2021 to January 2022,the 9 drugs that were previously intervened were reviewed according to the clinical pathway,and only two drugs were used,which were intervened,and both interventions were accepted and none of them were re-used.Conclusion The establishment of clinical pathways by pharmacists and physicians may be an effective way to promote clinical rational drug use.
作者
曾艳
马春玲
Zeng Yan;Ma Chunling(Department of Pharmacy,Xuanwu Hospital of Capital Medical University,Beijing 100053,China;Department of Pharmacy,Xiamen Xian Yue Hospital,Xiamen 361001,China)
出处
《实用药物与临床》
CAS
2022年第12期1087-1090,共4页
Practical Pharmacy and Clinical Remedies
基金
北京市科技计划课题(D181100000218002)。
关键词
肾功能减退
临床路径
干预
Renal impairment
Clinical pathway
Intervention
